PTKFY
Price
$13.50
Change
+$0.68 (+5.30%)
Updated
Dec 22 closing price
Capitalization
3.27B
Intraday BUY SELL Signals
RHHBY
Price
$52.50
Change
-$0.03 (-0.06%)
Updated
Dec 26 closing price
Capitalization
334.29B
33 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PTKFY vs RHHBY

Header iconPTKFY vs RHHBY Comparison
Open Charts PTKFY vs RHHBYBanner chart's image
PT Kalba Farma TBK
Price$13.50
Change+$0.68 (+5.30%)
Volume$171
Capitalization3.27B
Roche Holding
Price$52.50
Change-$0.03 (-0.06%)
Volume$412.19K
Capitalization334.29B
PTKFY vs RHHBY Comparison Chart in %
PTKFY
Daily Signal:
Gain/Loss:
RHHBY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
PTKFY vs. RHHBY commentary
Dec 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PTKFY is a StrongBuy and RHHBY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 28, 2025
Stock price -- (PTKFY: $13.50 vs. RHHBY: $52.50)
Brand notoriety: PTKFY and RHHBY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: PTKFY: 48% vs. RHHBY: 17%
Market capitalization -- PTKFY: $3.27B vs. RHHBY: $334.29B
PTKFY [@Pharmaceuticals: Major] is valued at $3.27B. RHHBY’s [@Pharmaceuticals: Major] market capitalization is $334.29B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $964.61B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $104.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PTKFY’s FA Score shows that 2 FA rating(s) are green whileRHHBY’s FA Score has 2 green FA rating(s).

  • PTKFY’s FA Score: 2 green, 3 red.
  • RHHBY’s FA Score: 2 green, 3 red.
According to our system of comparison, RHHBY is a better buy in the long-term than PTKFY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PTKFY’s TA Score shows that 3 TA indicator(s) are bullish while RHHBY’s TA Score has 4 bullish TA indicator(s).

  • PTKFY’s TA Score: 3 bullish, 5 bearish.
  • RHHBY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RHHBY is a better buy in the short-term than PTKFY.

Price Growth

PTKFY (@Pharmaceuticals: Major) experienced а +5.30% price change this week, while RHHBY (@Pharmaceuticals: Major) price change was +2.54% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.12%. For the same industry, the average monthly price growth was +1.24%, and the average quarterly price growth was +14.71%.

Reported Earning Dates

RHHBY is expected to report earnings on Jan 29, 2026.

Industries' Descriptions

@Pharmaceuticals: Major (+1.12% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RHHBY($334B) has a higher market cap than PTKFY($3.27B). RHHBY has higher P/E ratio than PTKFY: RHHBY (28.18) vs PTKFY (14.76). RHHBY YTD gains are higher at: 55.521 vs. PTKFY (-33.303). PTKFY has higher annual earnings (EBITDA): 5.02T vs. RHHBY (18B). PTKFY has more cash in the bank: 4.2T vs. RHHBY (12B). RHHBY has less debt than PTKFY: RHHBY (33B) vs PTKFY (520B). PTKFY has higher revenues than RHHBY: PTKFY (34.38T) vs RHHBY (63.5B).
PTKFYRHHBYPTKFY / RHHBY
Capitalization3.27B334B1%
EBITDA5.02T18B27,878%
Gain YTD-33.30355.521-60%
P/E Ratio14.7628.1852%
Revenue34.38T63.5B54,137%
Total Cash4.2T12B35,000%
Total Debt520B33B1,576%
FUNDAMENTALS RATINGS
PTKFY vs RHHBY: Fundamental Ratings
PTKFY
RHHBY
OUTLOOK RATING
1..100
3014
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
17
Undervalued
PROFIT vs RISK RATING
1..100
10049
SMR RATING
1..100
1599
PRICE GROWTH RATING
1..100
8040
P/E GROWTH RATING
1..100
9115
SEASONALITY SCORE
1..100
5550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PTKFY's Valuation (12) in the null industry is in the same range as RHHBY (17). This means that PTKFY’s stock grew similarly to RHHBY’s over the last 12 months.

RHHBY's Profit vs Risk Rating (49) in the null industry is somewhat better than the same rating for PTKFY (100). This means that RHHBY’s stock grew somewhat faster than PTKFY’s over the last 12 months.

PTKFY's SMR Rating (15) in the null industry is significantly better than the same rating for RHHBY (99). This means that PTKFY’s stock grew significantly faster than RHHBY’s over the last 12 months.

RHHBY's Price Growth Rating (40) in the null industry is somewhat better than the same rating for PTKFY (80). This means that RHHBY’s stock grew somewhat faster than PTKFY’s over the last 12 months.

RHHBY's P/E Growth Rating (15) in the null industry is significantly better than the same rating for PTKFY (91). This means that RHHBY’s stock grew significantly faster than PTKFY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PTKFYRHHBY
RSI
ODDS (%)
Bullish Trend 2 days ago
43%
Bearish Trend 2 days ago
50%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
48%
Bearish Trend 2 days ago
46%
Momentum
ODDS (%)
Bullish Trend 2 days ago
42%
Bullish Trend 2 days ago
51%
MACD
ODDS (%)
Bullish Trend 2 days ago
33%
Bullish Trend 2 days ago
47%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
25%
Bullish Trend 2 days ago
51%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
38%
Bullish Trend 2 days ago
51%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
54%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
47%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
38%
Aroon
ODDS (%)
Bearish Trend 2 days ago
21%
Bullish Trend 2 days ago
44%
View a ticker or compare two or three
Interact to see
Advertisement
PTKFY
Daily Signal:
Gain/Loss:
RHHBY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EMA49.140.06
+0.12%
Emera Inc
SMA31.52-0.05
-0.16%
Smartstop Self Storage REIT Inc
ACNB49.40-0.31
-0.62%
ACNB Corp
AMIX0.58-0.02
-3.81%
Autonomix Medical Inc
EQ1.50-0.11
-6.83%
Equillium

PTKFY and

Correlation & Price change

A.I.dvisor tells us that PTKFY and SNPHF have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTKFY and SNPHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTKFY
1D Price
Change %
PTKFY100%
N/A
SNPHF - PTKFY
6%
Poorly correlated
N/A
RHHVF - PTKFY
4%
Poorly correlated
-2.78%
RHHBY - PTKFY
2%
Poorly correlated
-0.06%
RHHBF - PTKFY
1%
Poorly correlated
-4.32%
OTSKF - PTKFY
0%
Poorly correlated
N/A
More

RHHBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHBY has been loosely correlated with RHHVF. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHBY jumps, then RHHVF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHBY
1D Price
Change %
RHHBY100%
-0.06%
RHHVF - RHHBY
65%
Loosely correlated
-2.78%
NVS - RHHBY
37%
Loosely correlated
+0.22%
JNJ - RHHBY
37%
Loosely correlated
-0.07%
RHHBF - RHHBY
32%
Poorly correlated
-4.32%
BMY - RHHBY
28%
Poorly correlated
-0.13%
More